
The three generations of obesity medicines
In this contribution to the Fall 2026 issue of DDW, Jon Rees, Co-Founder and CEO of MitoRx, talks about the journey obesity treatments are taking and where the opportunities lie. Few areas of medicine have been reshaped as fast as the pharmaceutical treatment of obesity. Read More












